Search by Drug Name or NDC

    NDC 71610-0448-20 Warfarin Sodium 5 mg/1 Details

    Warfarin Sodium 5 mg/1

    Warfarin Sodium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, LLC. The primary component is WARFARIN SODIUM.

    Product Information

    NDC 71610-0448
    Product ID 71610-448_c6ed46d9-0050-4c67-9a18-378ab6bf3ab3
    Associated GPIs 83200030200315
    GCN Sequence Number 006562
    GCN Sequence Number Description warfarin sodium TABLET 5 MG ORAL
    HIC3 M9L
    HIC3 Description ANTICOAGULANTS,COUMARIN TYPE
    GCN 25793
    HICL Sequence Number 002812
    HICL Sequence Number Description WARFARIN SODIUM
    Brand/Generic Generic
    Proprietary Name Warfarin Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Warfarin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name WARFARIN SODIUM
    Labeler Name Aphena Pharma Solutions - Tennessee, LLC
    Pharmaceutical Class Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090935
    Listing Certified Through 2024-12-31

    Package

    NDC 71610-0448-20 (71610044820)

    NDC Package Code 71610-448-20
    Billing NDC 71610044820
    Package 20 TABLET in 1 BOTTLE (71610-448-20)
    Marketing Start Date 2020-07-30
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 91f24482-d4cb-4a09-a97e-64f6e49071ee Details

    Revised: 8/2020